Cargando…

Galactomannan-Decorated Lipidic Nanocarrier for Gene Supplementation Therapy in Fabry Disease

Gene supplementation therapy with plasmid DNA (pDNA) represents one of the most promising strategies for the treatment of monogenic diseases such as Fabry disease (FD). In the present work, we developed a solid lipid nanoparticles (SLN)-based non-viral vector with a size below 100 nm, and decorated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodríguez-Castejón, Julen, Gómez-Aguado, Itziar, Beraza-Millor, Marina, Solinís, María Ángeles, del Pozo-Rodríguez, Ana, Rodríguez-Gascón, Alicia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324688/ https://www.ncbi.nlm.nih.gov/pubmed/35889565 http://dx.doi.org/10.3390/nano12142339

Ejemplares similares

Novel Golden Lipid Nanoparticles with Small Interference Ribonucleic Acid for Substrate Reduction Therapy in Fabry Disease
por: Beraza-Millor, Marina, et al.
Publicado: (2023)

mRNA-Based Nanomedicinal Products to Address Corneal Inflammation by Interleukin-10 Supplementation
por: Gómez-Aguado, Itziar, et al.
Publicado: (2021)

α-Galactosidase A Augmentation by Non-Viral Gene Therapy: Evaluation in Fabry Disease Mice
por: Rodríguez-Castejón, Julen, et al.
Publicado: (2021)

Nucleic Acid Delivery by Solid Lipid Nanoparticles Containing Switchable Lipids: Plasmid DNA vs. Messenger RNA
por: Gómez-Aguado, Itziar, et al.
Publicado: (2020)

Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives
por: Gómez-Aguado, Itziar, et al.
Publicado: (2020)

Topical Administration of SLN-Based Gene Therapy for the Treatment of Corneal Inflammation by De Novo IL-10 Production
por: Vicente-Pascual, Mónica, et al.
Publicado: (2020)

MMP-9 Downregulation with Lipid Nanoparticles for Inhibiting Corneal Neovascularization by Gene Silencing
por: Torrecilla, Josune, et al.
Publicado: (2019)

Multicomponent nanoparticles as nonviral vectors for the treatment of Fabry disease by gene therapy
por: Ruiz de Garibay, Aritz Pérez, et al.
Publicado: (2012)

Development of nucleic acid vaccines: use of self-amplifying RNA in lipid nanoparticles
por: Rodríguez-Gascón, Alicia, et al.
Publicado: (2014)

Lipid Nanoparticles as Carriers for RNAi against Viral Infections: Current Status and Future Perspectives
por: Torrecilla, Josune, et al.
Publicado: (2014)

The Role of PK/PD Analysis in the Development and Evaluation of Antimicrobials
por: Rodríguez-Gascón, Alicia, et al.
Publicado: (2021)

Comparison of the Performance of Two Galactomannan Detection Tests: Platelia Aspergillus Ag and Aspergillus Galactomannan Ag Virclia Monotest
por: Calero, Alba Leyva, et al.
Publicado: (2022)

Lipid-Based Nanocarriers for The Treatment of Glioblastoma
por: Iturrioz-Rodríguez, Nerea, et al.
Publicado: (2020)

Pharmacokinetic/Pharmacodynamic Analysis of Oral Calcium Fosfomycin: Are Urine Levels Sufficient to Ensure Efficacy for Urinary Tract Infections?
por: Rodríguez-Gascón, Alicia, et al.
Publicado: (2023)

Pharmacokinetic/Pharmacodynamic Analysis of Tedizolid Phosphate Compared to Linezolid for the Treatment of Infections Caused by Gram-Positive Bacteria
por: Rodríguez-Gascón, Alicia, et al.
Publicado: (2021)

Application of pharmacokinetic/pharmacodynamic analysis to evaluate the adequacy of antimicrobial therapy for pediatric acute otitis media in Spain before and after the introduction of the PCV7 vaccine
por: Ibar-Bariain, Maitane, et al.
Publicado: (2019)

Cholesterol Levels Affect the Performance of AuNPs-Decorated Thermo-Sensitive Liposomes as Nanocarriers for Controlled Doxorubicin Delivery
por: García, Mónica C., et al.
Publicado: (2021)

Targeted Delivery of Doxorubicin by Folic Acid-Decorated Dual Functional Nanocarrier
por: Lu, Jianqin, et al.
Publicado: (2014)

Use of Microfluidics to Prepare Lipid-Based Nanocarriers
por: Vogelaar, Alicia, et al.
Publicado: (2023)

Serum galactomannan in histoplasmosis in HIV
por: Baidya, Ankita, et al.
Publicado: (2022)

Design, development, and characterization of lipid nanocarriers-based epigallocatechin gallate delivery system for preventive and therapeutic supplementation
por: Frias, Iúri, et al.
Publicado: (2016)

Production performance, egg quality, plasma biochemical constituents and lipid metabolites of aged laying hens supplemented with incomplete degradation products of galactomannan
por: Tao, Yuheng, et al.
Publicado: (2021)

Dendrimer-decorated nanogels: Efficient nanocarriers for biodistribution in vivo and chemotherapy of ovarian carcinoma
por: Li, Xin, et al.
Publicado: (2021)

Correction to “Targeted Delivery of Doxorubicin by Folic Acid-Decorated Dual Functional Nanocarrier”
por: Lu, Jianqin, et al.
Publicado: (2019)

MIL-125-based nanocarrier decorated with Palladium complex for targeted drug delivery
por: Bagherzadeh, Mojtaba, et al.
Publicado: (2022)

Pseudomonas aeruginosa Susceptibility in Spain: Antimicrobial Activity and Resistance Suppression Evaluation by PK/PD Analysis
por: Valero, Ana, et al.
Publicado: (2021)

Disseminated Mucormycosis with Positive Aspergillus Galactomannan
por: Kitmiridou, Despoina, et al.
Publicado: (2018)

Case report: Enteral nutritional supplement as a likely cause of false-positive galactomannan testing()
por: Ng, Tong-Yong, et al.
Publicado: (2013)

Quantification of Ceftaroline in Human Plasma Using High-Performance Liquid Chromatography with Ultraviolet Detection: Application to Pharmacokinetic Studies
por: Alarcia-Lacalle, Ana, et al.
Publicado: (2021)

Optimization of levetiracetam dosing regimen in critically ill patients with augmented renal clearance: a Monte Carlo simulation study
por: Bilbao-Meseguer, Idoia, et al.
Publicado: (2022)

Lipid-Based Nanocarriers for RNA Delivery
por: Xue, Hui Yi, et al.
Publicado: (2015)

Lipid Nanocarriers for Hyperproliferative Skin Diseases
por: Souto, Eliana B., et al.
Publicado: (2021)

Bioinspired Lipid Nanocarriers for RNA Delivery
por: Golubovic, Alex, et al.
Publicado: (2023)

Ionizable lipids in bio-inspired nanocarriers
por: Zhdanov, Vladimir P.
Publicado: (2023)

Serum galactomannan levels in the diagnosis of invasive aspergillosis
por: Okuturlar, Yildiz, et al.
Publicado: (2015)

Mannose-Decorated Dendritic Polyglycerol Nanocarriers Drive Antiparasitic Drugs To Leishmania infantum-Infected Macrophages
por: Vossen, Laura I., et al.
Publicado: (2020)

Chemoenzymatic surface decoration of Nisin-shelled nanoemulsions: Novel targeted drug-nanocarriers for cancer applications
por: Hashad, Rania A., et al.
Publicado: (2022)

747. Diagnostic Performance of Bronchoalveolar Lavage Fluid Galactomannan Assay in Patients with Negative Serum Galactomannan Assay Suspected with Invasive Pulmonary Aspergillosis
por: Lim, So Yun, et al.
Publicado: (2020)

A novel local anesthetic system: transcriptional transactivator peptide-decorated nanocarriers for skin delivery of ropivacaine
por: Chen, Chuanyu, et al.
Publicado: (2017)

A pseudohomogeneous nanocarrier based on carbon quantum dots decorated with arginine as an efficient gene delivery vehicle
por: Rezaei, Aram, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_70b723jsg1d9vo5dgakkigsvoi